Table 2. Estimated prevalence of hepatitis C virus antibodies among immigrants in Canada, 2021.
| Population | Population size estimate | Prevalence (%) | Estimated number of immigrants with current or past HCV infection | ||||
|---|---|---|---|---|---|---|---|
| Point estimate | Lower bound | Upper bound | Point estimate | Lower bound | Upper bound | ||
| Immigrants from countries with low prevalence (<2%) | 7,082,480 | 0.96% | 0.56% | 1.54% | 67,892 | 39,530 | 109,319 |
| Immigrants from countries with intermediate-to-high prevalence (≥2%) | 1,276,405 | 4.04% | 2.87% | 6.68% | 51,540 | 36,686 | 85,316 |
| All immigrants | 8,358,885 | 1.43% | 0.91% | 2.33% | 119,432 | 76,216 | 194,635 |
Abbreviation: HCV, hepatitis C virus